RCMI Coordinating Center (RCMI CC) Header Logo

Connection

James Lillard to Cyclin-Dependent Kinase Inhibitor p21

Back to Details
This is a "connection" page, showing publications James Lillard has written about Cyclin-Dependent Kinase Inhibitor p21.
James Lillard
Connection Strength
0.145
Cyclin-Dependent Kinase Inhibitor p21
  1. Singh SK, Banerjee S, Acosta EP, Lillard JW, Singh R. Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway. Oncotarget. 2017 Mar 07; 8(10):17216-17228.
    View in: PubMed
    Score: 0.145
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support